HeartInsight

HeartInsight ⁠– Heart Failure Management Solution

Image
BIOTRONIK HeartInsight
Image
BIOTRONIK HeartInsight physician working at a desk
Image
HeartInsight-Physisician-looking-out-of-the-window-holding-his-glasses
Image
BIOTRONIK HeartInsight physician working on reporting dashboard
Image
HeartInsight-Woman-on-the-phone
Image
HeartInsight-Doctor-Portrait
Image
BIOTRONIK HeartInsight portrait of a female patient
Image
BIOTRONIK HeartInsight
Image
BIOTRONIK HeartInsight physician working at a desk
Image
HeartInsight-Physisician-looking-out-of-the-window-holding-his-glasses
Image
BIOTRONIK HeartInsight physician working on reporting dashboard
Image
HeartInsight-Woman-on-the-phone
Image
HeartInsight-Doctor-Portrait
Image
BIOTRONIK HeartInsight portrait of a female patient

Accurate Prediction. Proactive Care.

Heart failure is a leading cause of hospitalizations, and each hospitalization reflects a deteriorating prognosis for the patient.1,2 Managing heart failure patients is complex and requires significant resources.3 Health care providers face the difficult tasks of reducing costs and preventing hospitalizations through early identification and care of at-risk patients.

HeartInsight is a premium remote heart failure management solution that identifies patients at higher risk of decompensation early on. HeartInsight predicts heart failure hospitalizations – automatically and with high sensitivity – by combining multiple parameters into a single composite score, leading to one actionable alert. Industrywide it has the lowest false-alert rate and provides the earliest notifications of silent clinical changes that may lead to heart failure hospitalizations.4,5

HeartInsight streamlines your work by accurately identifying at-risk patients early on, so you can proactively care for those who need you the most. This may ultimately result in improved patient outcomes, as well as reduced clinical burden and costs associated with heart failure management.


BIOTRONIK-HeartInsight-Sensitivity

66%
Sensitivity

Predicting 2 out of 3 heart failure hospitalizations

BIOTRONIK-HeartInsight-alert-time

42
Days

Alert time (median)

 

BIOTRONIK-HeartInsight-alert-rate

0.7
False Alert Rate ppy

Only 1 false alert every 17 months

Overview

Clinical Facts

Clinical Workflow

Media

Overview

One Accurate Alert

For Identifying Patients at Higher Risk of Worsening Heart Failure

Receiving multiple inaccurate alerts with vague actionability is inefficient and time-consuming. HeartInsight is different: It provides a single alert to support confident decision making. This enables you to spend less time on false alerts and focus on the patients that need you most.

  • 66% alert sensitivity, predicting 2 out of 3 heart failure hospitalizations.6
  • Low alert burden, with <1 alert per patient year (ppy).8
  • 0.7 false alert rate ppy (industry-leading: one false alert every 17 months).5
  • One dedicated list for patient stratification helps prioritize tasks.

One Insightful Dashboard

For Supporting Confident Decision Making

With a growing cardiac device population, gathering and interpreting data to determine patient status is becoming more cumbersome and complex. HeartInsight helps streamline this process by organizing information clearly and intuitively. 

  • All-in-one alert: 8 parameters combined into one score and trend.
  • One dashboard and report for all relevant information.
  • 91% daily transmission success rate, based on the proven and reliable BIOTRONIK Home Monitoring® platform.6
  • Dedicated patient list, action log and pdf report to facilitate collaboration between clinicians.
  • Provides swift EHR integration, enabled by DataSync.

One Step Ahead

For Initiating a Meaningful Change

Heart failure patients often present with serious complications, highlighting the need for proactive care. HeartInsight provides a predictive alert to give you more time for contacting patients and initiating meaningful change. This may improve patient outcomes and reduce costly hospitalizations.

  • 42 days alert time for proactive care.*
  • Earliest notification of worsening heart failure signs even before patients report symptoms.4
  • Available for your new and existing ICD & CRT-D device patients.**
     
Clinical Facts

SELENE HF Multi-Center Study

The SELENE HF study assessed more than 900 patients and validated that the HeartInsight algorithm provides sensitive and timely prediction of impending heart failure decompensation with a low false-alert rate.

Key Findings

  • 66% alert sensitivity, predicting 2 out of 3 heart failure hospitalizations.6
  • 42 days alert time for proactive care.*
  • Low alert burden, with <1 alert per patient year (ppy).8
  • 0.7 false alert rate per patient year (industry-leading: one false alert every 17 months).5

All-in-One Alert

8 parameters combined into one score and trend.

HeartInsight’s sophisticated algorithm automatically combines 8 highly HF-relevant parameters in one score. When the score crosses a configurable threshold, HeartInsight provides a single, predictive alert identifying patients at higher risk of worsening heart failure. It is intended to allow clinical teams to care proactively and initiate a meaningful changes, even before patients may report symptoms.

  • HeartInsight calculates and weighs the score daily.
  • Triggers an alert notifying you when you need to be proactive.
BIOTRONIK-HeartInsight-Icon-Mean-Heart-Rate

Mean Heart Rate

BIOTRONIK-HeartInsight-Mean-Heart-Rate-at-Rest

Mean Heart Rate at Rest

BIOTRONIK-HeartInsight-Premature-Ventricular-Contractions

Premature Ventriculation Contractions

BIOTRONIK-HeartInsight-Atrial-Burden

Atrial Burden

BIOTRONIK-HeartInsight-Heart-Rate-Variability

Heart Rate Variability

Patient Activity

BIOTRONIK-HeartInsight-Thoratic-Impedance

Thoracic Impedance

BIOTRONIK-HeartInsight-Baseline-Risk-Stratifier

Baseline Risk Stratifier7 (optional)

Clinical Workflow

The HeartInsight Clinical Workflow

Manage your patients remotely with a predictive alert intended to provide you more time for contacting them, even before they report symptoms, and initiating a meaningful change,

BIOTRONIK HeartInsight Patient sleeping in bed with BIOTRONIK CardioMessenger on her nightstand

Monitor Your Patients Remotely with One Reliable Platform

  • HeartInsight is integrated into BIOTRONIK Home Monitoring®.
  • Easy plug-and-go setup.
  • Automatic daily transmission without patient involvement – for 91% transmission success.6
BIOTRONIK HeartInsight interface shown on computer.

Get Notified by One Accurate Alert

  • HeartInsight alerts you on increased risk of worsening patient condition.
  • Our sophisticated algorithm combines 8 highly relevant parameters into one score, calculated daily.
Physician working with BIOTRONIK HeartInsight on a computer.

Take Action Based on One Insightful Dashboard and Report ***

  • Interpret all relevant information in one place – to make confident decisions.
  • Provides swift EHR integration, enabled by DataSync.
BIOTRONIK HeartInsight Patient sitting on a green couch.

Improve Outcome

This may ultimately result in improved patient outcomes, decreased clinical burden, and reduced costs associated with heart failure management.
 

Media

ESC 2021 ⁠–⁠ Future Direction of Remote Cardiac Monitoring

How alert-based remote monitoring and predictive heart failure analytics can help improve diagnosis and treatment efficiency of cardiac device patients. Prof. Miloš Táborský (CZ), Prof. Niraj Varma (USA) and Dr. Antonio D’Onofrio (IT).


Related Products

BIOTRONIK Acticor 7 HF-T/QP

Cardiac resynchronization therapy (CRT) improves left ventricular function and clinical conditions in selected heart failure patients by pacing of both ventricles.

Rivacor 7 DR-T

An implantable cardioverter defibrillator (ICD) is able to sense, detect and treat life-threatening cardiac arrhythmias.

DX Technology is a unique hybrid system combining the advantages of both single- and dual-chamber ICD systems.


Contact

contact
Country/Region

1. Ambrosy AP et al. The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries. J Am Coll Cardiol 2014; 63:1123–33.

2. Gheorghiade M et al. Pathophysiologic Targets in the Early Phase of Acute Heart Failure Syndromes. Am J Cardiol; 2005; 96:11G–17G.

3. Ponikowski Pet al. HF preventing disease and death worldwide. ESC Heart Fail 2014 Sep;1(1):4–25.

4. Comparison of alerting time in validation studies: D’Onofrio et al. Europace 2021 doi:10.1093/europace/euab170; Boehmer JP et al. J Am Coll Cardiol Heart Fail. 2017 Mar, 5 (3) 216–225; Cowie MR et al. European Heart Journal (2013) 34, 2472–2480 doi:10.1093/eurheartj/eht083.

5. Comparison of false alert rate in validation studies: D’Onofrio et al. Europace 2021 doi:10.1093/europace/euab170; Boehmer JP et al. J Am Coll Cardiol Heart Fail. 2017 Mar, 5 (3) 216–225; Cowie MR et al. European Heart Journal (2013) 34, 2472–2480 doi:10.1093/eurheartj/eht083.

6. D’Onofrio A et al. Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalisations: results from the SELENE HF study. Europace 2021 doi: 10.1093/europace/euab170.

7. Based on the Seattle Heart Failure Model: Levy WC et al. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure. Circulation 2006, Mar 21;113(11):1424-33.

8. Data on file.

* 42 days refers to median alert time.

** Available for Acticor/Rivacor, Ilivia Neo/Intica Neo, Ilivia/Intica /Inlexa -5 and -7 series ICD DX/DC and CRT-D.

*** Based on current standard practice and clinical judgement

Disclaimer: HeartInsight is approved and available in CE regions only.